0001493152-24-012340.txt : 20240401 0001493152-24-012340.hdr.sgml : 20240401 20240401160137 ACCESSION NUMBER: 0001493152-24-012340 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240328 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Riley Jeffrey Scott CENTRAL INDEX KEY: 0001487645 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40237 FILM NUMBER: 24809014 MAIL ADDRESS: STREET 1: C/O ADEONA PHARMACEUTICALS, INC STREET 2: 3930 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gain Therapeutics, Inc. CENTRAL INDEX KEY: 0001819411 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851726310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (301) 500-1556 MAIL ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 ownership.xml X0508 4 2024-03-28 0 0001819411 Gain Therapeutics, Inc. GANX 0001487645 Riley Jeffrey Scott C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220 BETHESDA MD 20814 1 0 0 0 0 Common Stock 2024-03-28 4 P 0 30000 3.859 A 30000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7098 to $3.924, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Jeffrey Scott Riley 2024-04-01